These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12916337)

  • 1. [National practice guidelines. New aspects in therapy of type 2 diabetes mellitus].
    Haupt A; Häring HU; Matthaei S
    MMW Fortschr Med; 2003 Jun; 145(26):41-6. PubMed ID: 12916337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmaceutical therapy of diabetes mellitus type 2].
    Laubner K; Seufert J
    Internist (Berl); 2007 Mar; 48(3):297-308; quiz 309. PubMed ID: 17260149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin in type 2 diabetes: a useful alternative despite limited assessment based on surrogate endpoints.
    Prescrire Int; 2005 Oct; 14(79):187-93. PubMed ID: 16285076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.
    Yurgin N; Secnik K; Lage MJ
    Clin Ther; 2007 Feb; 29(2):316-25. PubMed ID: 17472823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Insulin therapy of type 2 diabetes: from simple to flexible--three strategies are available].
    Liebl A
    MMW Fortschr Med; 2012 Nov; 154 Spec No 3():66-71; quiz 72-3. PubMed ID: 23724722
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of adolescents with type 2 diabetes].
    Kapellen TM; Böttner A; Galler A; Raile K; Nietzschmann U; Kiess W
    Klin Padiatr; 2004; 216(2):57-61. PubMed ID: 15106074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes treatment intensification and associated changes in HbA1c and body mass index: a cohort study.
    Roumie CL; Greevy RA; Grijalva CG; Hung AM; Liu X; Griffin MR
    BMC Endocr Disord; 2016 Jun; 16(1):32. PubMed ID: 27255309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.
    Ushakova O; Sokolovskaya V; Morozova A; Valeeva F; Zanozina O; Sazonova O; Zhadanova E; Starceva M; Kazakova E; Saifullina M; Shapiro I; Tarasov A; Al-Tayar B; Starkova N
    Clin Ther; 2007 Nov; 29(11):2374-84. PubMed ID: 18158078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New, expensive antidiabetics for the treatment of type-2 diabetes--contra].
    Nawroth P
    Dtsch Med Wochenschr; 2010 May; 135(18):923. PubMed ID: 20425679
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolic control and vascular diseases under oral antidiabetic drug versus insulin therapy and/or diet alone during the first year of hemodialysis in type 2 diabetic patients with ESRD.
    Biesenbach G; Bodlaj G; Ebner S; Biesenbach P; Pieringer H
    Int Urol Nephrol; 2011 Dec; 43(4):1155-60. PubMed ID: 20640938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [When oral therapy of type 2 diabetes fails--basal insulin is more effective than change in life style (interview by Dr. Thomas Meissner)].
    MMW Fortschr Med; 2008 Aug; 150(32-35):28-9. PubMed ID: 19006878
    [No Abstract]   [Full Text] [Related]  

  • 12. Study rationale and design of the CIMT trial: the Copenhagen Insulin and Metformin Therapy trial.
    Lundby Christensen L; Almdal T; Boesgaard T; Breum L; Dunn E; Gade-Rasmussen B; Gluud C; Hedetoft C; Jarloev A; Jensen T; Krarup T; Johansen LB; Lund SS; Madsbad S; Mathiesen E; Moelvig J; Nielsen F; Perrild H; Pedersen O; Roeder M; Sneppen SB; Snorgaard O; Tarnow L; Thorsteinsson B; Vaag A; Vestergaard H; Wetterslev J; Wiinberg N;
    Diabetes Obes Metab; 2009 Apr; 11(4):315-22. PubMed ID: 19267709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensification of antihyperglycemic therapy among patients with incident diabetes: a Surveillance Prevention and Management of Diabetes Mellitus (SUPREME-DM) study.
    Raebel MA; Ellis JL; Schroeder EB; Xu S; O'Connor PJ; Segal JB; Butler MG; Schmittdiel JA; Kirchner HL; Goodrich GK; Lawrence JM; Nichols GA; Newton KM; Pathak RD; Steiner JF
    Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):699-710. PubMed ID: 24639086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group.
    Ann Intern Med; 1998 Feb; 128(3):165-75. PubMed ID: 9454524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of diabetes mellitus in patients with angiopathies].
    Lohmann T
    Z Kardiol; 2005; 94 Suppl 4():IV/28-30. PubMed ID: 16416060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiating insulin therapy in type 2 diabetic patients failing on oral hypoglycemic agents: basal or prandial insulin? The APOLLO trial and beyond.
    Bretzel RG; Eckhard M; Landgraf W; Owens DR; Linn T
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S260-5. PubMed ID: 19875561
    [No Abstract]   [Full Text] [Related]  

  • 18. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of additional metformin or NPH insulin to mealtime insulin lispro therapy with mealtime human insulin therapy in secondary OAD failure.
    Altuntas Y; Ozen B; Ozturk B; Sengul A; Ucak S; Ersoy O; Karul S
    Diabetes Obes Metab; 2003 Nov; 5(6):371-8. PubMed ID: 14617222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical practice guidelines in type 2 diabetes mellitus: similarities and discrepancies].
    Soidán FJ
    Med Clin (Barc); 2010 Sep; 135 Suppl 2():6-8. PubMed ID: 21420531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.